Introduction of a Novel GH Auto-Injector for Once-weekly Administration of TransCon hGH

Background: TransCon hGH is an investigational long-acting prodrug of growth hormone (hGH; somatropin) in development as a once-weekly therapy for pediatric growth hormone deficiency (GHD). We evaluated the usability of TransCon hGH in dual-chamber cartridges (DCCs)

Source: Journal of Pediatric Nursing - April 30, 2020 Category: Nursing Authors: Kimberly Walsh, Donna Campbell, Joe Permuy, Michael Henson, Larry Rodriguez, Brittany Machus, April Shiver, Katharine Smith Tags: Product-Based Research Source Type: research